Evidence Generation
We design and deliver robust real-world evidence strategies that support regulatory, payer, HTA, and clinical decision-making across the product lifecycle.



How We Generate Decision-Grade Real-World Evidence
Real-world evidence must do more than describe what happened in practice. It must answer a clearly defined stakeholder question with scientific rigor, transparent methodology, and data that is fit for purpose.
Our approach begins with the decision that evidence needs to support, whether for regulatory, market access, payer, HTA, safety, comparative effectiveness, or clinical use. We then design the right study strategy, identify and curate the most relevant data sources, and apply robust analytical methods to generate credible, actionable insights.
By combining domain expertise in epidemiology, biostatistics, clinical research, data management, and analytics, we help sponsors transform real-world data into evidence that is relevant, defensible, and ready for decision-making.
Generation Framework
End-to-End Real-World Evidence Capabilities
We combine strategy, epidemiology, biostatistics, HEOR, safety, and regulatory expertise to generate decision-grade evidence across the product lifecycle.
Evidence Strategy & Study Design
- Define the research question, study design, endpoints, comparators, and evidence plan aligned to stakeholder needs.
Data Curation & Harmonization
- Curate, standardize, and validate real-world data from EHR, claims, registries, PROs, and other sources for fit-for-purpose use.
Analytics Pipelines & Evidence Generation
- Build reproducible analytical workflows that transform curated data into credible, decision-ready evidence.
Comparative Effectiveness & Outcomes Research
- Evaluate real-world treatment performance using robust methods for comparative and outcomes-based evidence generation.
Post-Authorization & Safety Studies
- Support long-term safety, effectiveness, and regulatory commitments through post-authorization evidence generation.
Market Access, HTA & Specialty Evidence
- Generate evidence that supports payer, HTA, reimbursement, and specialty population decision-making.
From Research Question to Informed Decision
We follow a structured evidence generation lifecycle that begins with the decision to be supported, builds the right study and data strategy, and delivers credible insights for stakeholder decision-making.
Research Question
Define the stakeholder question, decision context, target population, comparators, and endpoints.
Evidence Strategy & Study Design
Design the right study approach, methodology, and evidence plan.
Data Sourcing & Curation
Identify, curate, harmonize, and validate fit-for-purpose real-world data.
Analysis & Evidence Generation
Apply rigorous analytical methods to generate credible, decision-grade findings.
Interpretation & Reporting
Translate results into clear, stakeholder-ready evidence outputs.
Informed Decision
Enable confident decisions across regulatory, payer, HTA, clinical, and market access settings.
Technology, Data & IQA Solutions
Our evidence generation capabilities are supported by a modern data and technology foundation, strengthened by IQA’s platforms and accelerators for curation, quality, prospective data capture, protocol readiness, coding, and structured evidence workflows.
Why Inductive Quotient
We combine scientific rigor, delivery expertise, and technology-enabled execution to help sponsors generate real-world evidence that is credible, decision-ready, and aligned to the needs of regulators, payers, HTA bodies, and clinical stakeholders.
Integrated RWE Expertise
Our multidisciplinary teams bring together epidemiology, biostatistics, clinical research, data management, HEOR, and regulatory-aligned thinking to design and deliver fit-for-purpose evidence.
Technology-Enabled Execution
Our evidence generation approach is strengthened by IQA solutions and accelerators that support data curation, quality oversight, analytics workflows, prospective data capture, coding, and structured evidence generation.
Decision-Grade Scientific Rigor
We focus on clear research questions, fit-for-purpose data, transparent methods, bias-aware study design, and stakeholder-ready outputs that support confident decision-making.
End-to-End Delivery Model
From evidence strategy and study design through data curation, analysis, interpretation, and reporting, we support the full evidence generation lifecycle with accountability and consistency.
Flexible Engagement Approach
Whether you need support for a targeted study, a broader evidence program, or embedded functional expertise, we adapt to your delivery model and evidence priorities.
Built for Real-World Complexity
We work across diverse real-world data sources, evolving evidence expectations, and complex stakeholder needs to generate evidence that is relevant, defensible, and actionable.
What Evidence Gap Is Slowing Your Product's Journey?
Tell us your product, your market and the decision you are trying to influence. We will design an evidence strategy that generates the specific RWE your stakeholders need to act with confidence.
